NBAF

National Bankers Association Foundation, with Wells Fargo Support, Will Underwrite SCORE Training and Education to Improve Founders' Financial Acumen

Retrieved on: 
Thursday, February 29, 2024

WASHINGTON, Feb. 29, 2024 /PRNewswire-PRWeb/ -- The SCORE Foundation, the philanthropic arm of SCORE, the nation's largest network of volunteer, expert business mentors, today announced that a new, first-time sponsorship from the National Bankers Association Foundation (NBAF) with support from Wells Fargo, will underwrite SCORE training to increase the financial knowledge and acumen of Black and minority small business owners.

Key Points: 
  • WASHINGTON, Feb. 29, 2024 /PRNewswire-PRWeb/ -- The SCORE Foundation, the philanthropic arm of SCORE , the nation's largest network of volunteer, expert business mentors, today announced that a new, first-time sponsorship from the National Bankers Association Foundation (NBAF) with support from Wells Fargo, will underwrite SCORE training to increase the financial knowledge and acumen of Black and minority small business owners.
  • Training will include a series of live, national virtual workshops and educational materials and templates.
  • "We are thrilled to support the National Bankers Association Foundation in empowering small business owners to take advantage of their financial futures," said Michael Martino, head of Diverse Customer Segments for Consumer, Small and Business Banking at Wells Fargo.
  • "We are grateful to National Bankers Association Foundation and Wells Fargo for the impact that their support can have in leveling the playing field for economic opportunity for Black business owners," said Liz Sara , president of the SCORE Foundation.

MEDGENE SIGNS AGREEMENTS WITH U.S. DEPARTMENT OF AGRICULTURE TO DEVELOP PLATFORM VACCINES FOR FOREIGN ANIMAL DISEASES

Retrieved on: 
Wednesday, October 11, 2023

BROOKINGS, S.D., Oct. 11, 2023 /PRNewswire/ -- Important cooperative agreements were recently signed between the USDA's Agricultural Research Service (USDA-ARS) and Medgene, an animal health company that produces highly-targeted platform vaccines.  The agreements are designed to apply Medgene's proprietary platform vaccine technologies against two well-known foreign animal diseases:  Nipah Virus and Rift Valley Fever. 

Key Points: 
  • The agreements are designed to apply Medgene's proprietary platform vaccine technologies against two well-known foreign animal diseases:  Nipah Virus and Rift Valley Fever.
  • "As important as American agriculture is to the world, we must be prepared to address these and other diseases now."
  • The Rift Valley Fever agreement is to develop an assay to measure the antibody activity of Medgene's platform vaccines in order to differentiate an infected animal from a vaccinated animal.
  • As important as American agriculture is to the world, we must be prepared to address these and other diseases now.

Sitero Launches Biosafety Advisory Board, Naming Renowned Experts to Provide Guidance on Biosafety Compliance

Retrieved on: 
Tuesday, January 10, 2023

MIAMI, Jan. 10, 2023 /PRNewswire/ -- Sitero has launched a first-of-its kind Biosafety Advisory Board and named several renowned biosafety experts as inaugural board members.

Key Points: 
  • MIAMI, Jan. 10, 2023 /PRNewswire/ -- Sitero has launched a first-of-its kind Biosafety Advisory Board and named several renowned biosafety experts as inaugural board members.
  • The board will advise Sitero on its biosafety services, helping ensure that the company provides industry-leading support for biosafety compliance.
  • The Sitero Biosafety Advisory board is the latest investment that Sitero is making in their Biosafety and IBC offerings due to their recent and expected continued growth in the space.
  • "Their efforts will be instrumental in delivering best practices in biosafety to inform our work at Sitero and advance the biosafety profession."

Sitero Introduces IBC Services

Retrieved on: 
Thursday, November 17, 2022

MIAMI, Nov. 17, 2022 /PRNewswire/ -- Today, Sitero announces a new Biosafety service offering for clinical and research sites to support their Biosafety compliance management. The services will be led by Dr. Sarah Ziegler, an expert in the field of Biosafety with years of experience at institutions across the country. Institutional Biosafety Committees (IBCs) are an NIH requirement for specific types of research. Sitero's IBC Services will give customers a configurable, technology-enabled solution when choosing an IBC provider. IBC compliance at clinical trial locations is growing rapidly, with an increasing number of Human Gene Transfer (HGT) products entering trials, but there exists a limited number of IBC suppliers.

Key Points: 
  • Sitero's IBC Services will give customers a configurable, technology-enabled solution when choosing an IBC provider.
  • "I am excited to offer my extensive experience and Biosafety expertise to help sites operate in a safe environment and navigate the hurdles of the NIH," said Dr. Ziegler, VP of Biosafety and IBC Services at Sitero.
  • "Ethics, compliance and innovation drive all our offerings at Sitero," said David Ingraham, President at Sitero.
  • Dr. Sarah Ziegler is responsible for leading the Biosafety and IBC services at Sitero.

NBAF Appoints Oronike Odeleye as New Artistic Director Beginning November 1st, 2022

Retrieved on: 
Wednesday, November 2, 2022

ATLANTA, Nov. 2, 2022 /PRNewswire-PRWeb/ -- NBAF is excited to announce the appointment of Oronike Odeleye to the prestigious role of Artistic Director as of November 1, 2022.

Key Points: 
  • ATLANTA, Nov. 2, 2022 /PRNewswire-PRWeb/ -- NBAF is excited to announce the appointment of Oronike Odeleye to the prestigious role of Artistic Director as of November 1, 2022.
  • "NBAF seeks to ensure that the art and stories of Black people are increasingly presented and valued," said Stephanie Owens, Executive Director of NBAF.
  • She will lead NBAF's artistic vision and direction, ensuring the organization continues to expand its reach and impact across communities."
  • Odeleye succeeds Artistic Director, Tiffany Latrice Williams, Founder and Executive Director of the arts incubator, TILA Studios.

Sitero Celebrates National Biosafety Month With the Launch of Biosafety Consulting Services

Retrieved on: 
Tuesday, October 4, 2022

Sitero provides a full suite of offerings to customers, ranging from full-spectrum biosafety programs to bespoke services that supplement customers' in-house capabilities and allow them to focus on their highest priority.

Key Points: 
  • Sitero provides a full suite of offerings to customers, ranging from full-spectrum biosafety programs to bespoke services that supplement customers' in-house capabilities and allow them to focus on their highest priority.
  • While Sitero offers services such as training, program reviews and compliance audits, they have the biosafety expertise and technology-enabled solutions to build a flexible offering to meet any client's needs.
  • "We are excited to be celebrating Biosafety month with the launch of Sitero's Biosafety Consulting services," said, Dr. Sarah Ziegler, VP of Biosafety at Sitero.
  • Dr. Ziegler is responsible for leading the Biosafety and IBC services at Sitero.

Scorpion Biological Services Announces New Kansas Commercial Biomanufacturing Facility

Retrieved on: 
Tuesday, April 26, 2022

MANHATTAN, Kan., April 26, 2022 /PRNewswire/ -- Biopharmaceutical contract development and manufacturing organization (CDMO) Scorpion Biological Services (Scorpion) today announced a planned development partnership with a private developer, the State of Kansas, and local and university affiliates, which will support the construction of a new biodefense-focused large molecule and biologics biomanufacturing facility in Manhattan, Kansas.

Key Points: 
  • MANHATTAN, Kan., April 26, 2022 /PRNewswire/ -- Biopharmaceutical contract development and manufacturing organization (CDMO) Scorpion Biological Services (Scorpion) today announced a planned development partnership with a private developer, the State of Kansas, and local and university affiliates, which will support the construction of a new biodefense-focused large molecule and biologics biomanufacturing facility in Manhattan, Kansas.
  • The design and engineering of the facility is being led by CRB Group, a nationally recognized firm focused on designing and building biomanufacturing facilities.
  • Upon completion, Scorpion projects that the facility will have a billion-dollar impact on the State of Kansas, and employ over 500 individuals, largely from the local Kansas talent pool.
  • Scorpion Biological Services is working to expand the reach of precision medicine to more people within multiple therapeutic areas.

Heat Biologics’ Scorpion Subsidiary Announces Planned Development of New Kansas Commercial/Biodefense Biomanufacturing Facility

Retrieved on: 
Monday, April 18, 2022

DURHAM, N.C., April 18, 2022 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (Heat) (NYSE American: HTBX), a clinical-stage biopharmaceutical company focused on developing novel biodefense assets and first-in-class therapies to modulate the immune system, today announced a planned development partnership of its Scorpion Biological Services subsidiary with a private developer, the State of Kansas and local and university affiliates, to support the development of a new biodefense-focused large molecule and biologics biomanufacturing facility in Manhattan, Kansas. Manhattan is the home of Kansas State University (K-State), its Biosecurity Research Institute (BRI), and the National Bio and Agro-Defense Facility (NBAF).

Key Points: 
  • Manhattan is the home of Kansas State University (K-State), its Biosecurity Research Institute (BRI), and the National Bio and Agro-Defense Facility (NBAF).
  • The facility is expected to have a billion-dollar economic impact within the State of Kansas.
  • David Halverson, President of Heats Scorpion subsidiary, noted, We are very excited to break ground on this new facility.
  • Jeff Wolf, Chief Executive Officer of Heat, commented, Today, we are very proud to unveil our plans for our newest biomanufacturing facility in Manhattan, Kansas.